Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback